Symbol
SGMT on Nasdaq
Investment type
Equity / Series A Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned
0 shares
Security Ownership %
0%

New Enterprise Associates 13, L.P. ownership in Sagimet Biosciences Inc. Series A Common Stock, $0.0001 par value per share (SGMT)

13 May 2025 - New Enterprise Associates 13, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Sagimet Biosciences Inc. Series A Common Stock, $0.0001 par value per share (SGMT). This represents 0% ownership of the company. This is the first filing by NEW ENTERPRISE ASSOCIATES 13 LP disclosing ownership of Sagimet Biosciences Inc. Series A Common Stock, $0.0001 par value per share (SGMT).